Android app on Google Play

Unusual 11 Mid-Day Movers 12/10: (ACUR) (UNXL) (IVAN) Higher; (ZGNX) (CSFS) (HEB) Lower

December 10, 2012 1:02 PM EST Send to a Friend
Zogenix, Inc. (Nasdaq: ZGNX) 46.8% LOWER; announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) voted 2-11 [with 1 abstention] against the approval of Zohydro ER (hydrocodone bitartrate extended-release capsules), an extended-release formulation of hydrocodone without acetaminophen, for the management of moderate-to-severe chronic pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Acura Pharmaceuticals, Inc. (Nasdaq: ACUR) 39.2% HIGHER; announced the launch of Nexafed? [pseudoephedrine hydrochloride (HCl)], a 30 mg immediate-release next generation pseudoephedrine product, combining effective nasal-congestion relief with a unique technology that disrupts the conversion of pseudoephedrine into the dangerous drug, methamphetamine.

Uni-Pixel, Inc. (Nasdaq: UNXL) 26.2% HIGHER; continuing higher Monday from an announcement last week that it entered an agreement with a manufacturer of personal computers to develop and introduce products that feature next-generation touch screens based on UniPixel's UniBoss pro-cap, multi-touch sensor film.

Ivanhoe Energy Inc. (Nasdaq: IVAN) 33.9% HIGHER; will make a presentation updating on strategy and current activities at the 2012 Canadian Association of Petroleum Producers (CAPP) Investment Symposium tomorrow.

Geron Corp (Nasdaq: GERN) 25.5% HIGHER; announced positive clinical results from the Phase 2 trial of imetelstat, its first-in-class telomerase inhibitor, in patients with essential thrombocythemia (ET) - a chronic blood disorder.

The Cash Store Financial Services Inc. (NYSE: CSFS) 25.1% LOWER; announced that it will restate the previously issued unaudited consolidated interim financial statements ("interim financial statements") for the three and six months ended March 31, 2012 and three and nine months ended June 30, 2012.

Celldex Therapeutics, Inc. (Nasdaq: CLDX) 23.0% HIGHER; said CDX-011 met some primary endpoints in Phase 2b EMERGE study in patients with glycoprotein NMB (GPNMB)-expressing, advanced, heavily pretreated breast cancer.

Intermec, Inc. (NYSE: IN) 23.9% HIGHER; Honeywell (NYSE: HON) will acquire Intermec for $10 per share.

Hemispherx Biopharma, Inc. (AMEX: HEB) 11.1% LOWER; lower on a SeekingAlpha article out over the weekend, which highlights uncertainty over regulatory approval for Ampligen.

NQ Mobile Inc. (NYSE: NQ) 9.4% LOWER; NQ falling back below the key $6 level today on volume.

Diamond Foods, Inc. (Nasdaq: DMND) 8.7% LOWER; reported Q4 EPS of $0.05, versus $0.23 reported last year. Revenue for the quarter came in at $223.99 million, versus $234.72 million reported last year.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.




You May Also Be Interested In


Related Categories

Special Reports

Related Entities

Unusual 11 Mid-Day Movers

Add Your Comment